Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 9Recruiting 3Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 29Carboplatin 15Nivolumab 13Cisplatin 12atezolizumab 11venetoclax 10Paclitaxel 10Pemetrexed 9Ipilimumab 9Docetaxel 9Radiotherapy 8Bevacizumab 8fludarabine 7durvalumab 7Specimen Handling 7Gemcitabine 7Cyclophosphamide 7Cetuximab 7fludarabine phosphate 6Practice Guidelines as Topic 6Biopsy 6tislelizumab 5enzalutamide 5Trastuzumab 5Standard of Care 5Radiosurgery 5Radiation 5Oxaliplatin 5Magnetic Resonance Spectroscopy 5Injections 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × gallium 68 PSMA-11 × 90 days × Clear all
NCT04716725 2026-05-15

68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer

University of California, San Francisco

Phase 2 Terminated
15 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡